Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Nitroacetophenone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.
Novel Pd-catalyzed C-H activation method for o-nitroacetophenone. Safe, eco-friendly route offering high regioselectivity for pharma intermediates.
Novel m-fluoroaniline route for Hepatitis C intermediate. High yield, low cost, scalable process for global pharma supply chains.